Intestinal Microbiome
10
3
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners.
Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study
Effects of Caloric Restriction and Exercise on Body Weight, Immune Function, and Intestinal Flora
Effects of Diet and Exercise Interventions on Cardiometabolic Risk Markers, Executive Function, and Intestinal Flora
LIMIT Early Adiposity Rebound in Children
Cesarean Section and Intestinal Flora of the Newborn